| Accession | Title | Sample type | Organism(s) | Ch | Platform | Series | Supplementary | Contact | Release date |
|---|---|---|---|---|---|---|---|---|---|
 Filter
|
Mus musculus
|
RESULTS
|
Paul Marker
|
||||||
| GSM5924227 |
Tamoxifen-control replicate 1
|
SRA |
|
1 |
|
Paul Marker | Jan 01, 2023 | ||
| GSM5924228 |
Tamoxifen-control replicate 2
|
SRA |
|
1 |
|
Paul Marker | Jan 01, 2023 | ||
| GSM5924229 |
Tamoxifen-control replicate 3
|
SRA |
|
1 |
|
Paul Marker | Jan 01, 2023 | ||
| GSM5924230 |
Ghr deletion replicate 1
|
SRA |
|
1 |
|
Paul Marker | Jan 01, 2023 | ||
| GSM5924231 |
Ghr deletion replicate 2
|
SRA |
|
1 |
|
Paul Marker | Jan 01, 2023 | ||
| GSM5928110 |
Mouse dorsolateral prostate Tamoxifen-control replicate 1
|
SRA |
|
1 |
|
Paul Marker | Jan 01, 2023 | ||
| GSM5928111 |
Mouse dorsolateral prostate Tamoxifen-control replicate 2
|
SRA |
|
1 |
|
Paul Marker | Jan 01, 2023 | ||
| GSM5928112 |
Mouse dorsolateral prostate Ghr deletion replicate 1
|
SRA |
|
1 |
|
Paul Marker | Jan 01, 2023 | ||
| GSM5928113 |
Mouse dorsolateral prostate Ghr deletion replicate 2
|
SRA |
|
1 |
|
Paul Marker | Jan 01, 2023 | ||
| GSM5928114 |
Mouse dorsolateral prostate Ghr deletion replicate 3
|
SRA |
|
1 |
|
Paul Marker | Jan 01, 2023 | ||
| GSM5685095 |
V0194L2: Vehicle-treated replicate 1
|
SRA |
|
1 |
|
Paul Marker | Apr 01, 2022 | ||
| GSM5685096 |
V0203L2: Vehicle-treated replicate 2
|
SRA |
|
1 |
|
Paul Marker | Apr 01, 2022 | ||
| GSM5685097 |
V0204L2: Vehicle-treated replicate 3
|
SRA |
|
1 |
|
Paul Marker | Apr 01, 2022 | ||
| GSM5685098 |
P0186L2: Drug-treated replicate 1
|
SRA |
|
1 |
|
Paul Marker | Apr 01, 2022 | ||
| GSM5685099 |
P0189R2: Drug-treated replicate 2
|
SRA |
|
1 |
|
Paul Marker | Apr 01, 2022 | ||
| GSM5685100 |
P0190L2: Drug-treated replicate 3
|
SRA |
|
1 |
|
Paul Marker | Apr 01, 2022 |
